产品名称 | NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag |
---|---|
目录号 | NBL-241992 |
别名 | TRAIL R1/DR4/TNFRSF10A; DR4; CD261; TNFRSF10A; TRAIL-R; APO2; TRAIL R1; MGC9365 |
外观 | see COA |
分子量 | Pro34-Asn239 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O00220 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241992-100ug | 100ug | Inquire | Inquire | |
NBL-241992-1mg | 1mg | Inquire | Inquire | |
NBL-241992-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag
Catalog#:
NBL-241992
Description:
NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag(Cat#NBL-241992) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Pro34-Asn239.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
TRAIL R1/DR4/TNFRSF10A; DR4; CD261; TNFRSF10A; TRAIL-R; APO2; TRAIL R1; MGC9365
Target Information:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces apoptosis selectively via its interaction with the death receptors TRAILR1/DR4 and TRAILR2/DR5 in a wide range of cancers, while sparing normal cells. Despite its tremendous potential for cancer therapeutics, the translation of TRAIL into the clinic has been confounded by TRAIL-resistant cancer populations.
Amino Acid Sequence:
Pro34-Asn239
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.